Articles

The transaction includes Unloxcyt (cosibelimab-ipdl), which was approved by FDA in December 2024 for treatment of adults with cutaneous squamous cell carcinoma (cSCC).

Sun Pharma Agrees to Acquire Checkpoint Therapeutics

Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.

FDA Approves First Generics of Rivaroxaban Tablets

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape. 

Industry Outlook 2025: Fostering the Development of Biotech in Europe

The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.

New Almac Pharma Services Commercial Manufacturing Facility Opens in Northern Ireland

Sterimove will make its North American debut at the April 1–3, 2025 event.

Stäubli Robotics Previews World’s First Cleanroom Mobile Robot for INTERPHEX Display

Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with Pharmaceutical Technology®.

Industry Outlook 2025: US Political Motivations and Legislative Discussions

The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.

Noramco Group Establishes Sterile Injectable Manufacturing Capabilities with $25 Million Investment

Pharmaceutical Technology® chats with Miguel Forte from ISCT and Kiji Therapeutics about expectations for 2025 and the future technology agenda for industry.

Industry Outlook 2025: Setting the Tone for Industry

Supporting the prosperity of women in science fields benefits the bio/pharmaceutical industry.

International Women’s Day 2025: Celebrating Women in Science

Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions. 

News